Consensus and controversy in advanced urologic cancers: Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025
A
Albert Jang
(Division of Medical Oncology, Department of Oncology Mayo Clinic Rochester Minnesota USA)
Y
Yousef Zakharia
(Division of Hematology and Medical Oncology, Department of Internal Medicine Mayo Clinic Phoenix Arizona USA)
P
Pedro C. Barata
(Division of Solid Tumor Oncology, Department of Medicine University Hospitals, Cleveland Medical Center Case Western Reserve University School of Medicine Cleveland Ohio USA)
Article Details
Volume / Issue
Vol. 76, Issue 1
Published
January 01, 2026
ISSN
0007-9235
Publisher
Wiley
Authors (3)
A
Albert Jang
Division of Medical Oncology, Department of Oncology Mayo Clinic Rochester Minnesota USA
Y
Yousef Zakharia
Division of Hematology and Medical Oncology, Department of Internal Medicine Mayo Clinic Phoenix Arizona USA
P
Pedro C. Barata
Division of Solid Tumor Oncology, Department of Medicine University Hospitals, Cleveland Medical Center Case Western Reserve University School of Medicine Cleveland Ohio USA
Related Articles from this Journal
Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates
Xia Wu, Heather Landau et al.
May 2026
10.3322/caac.70092
Screening for colorectal cancer
May 2026
10.3322/caac.70087
Correction to “Integrating multimodal management and molecular profiling in a patient with BRAF V600E–positive melanoma and brain metastases”
May 2026
10.3322/caac.70093
Blood tests for colorectal cancer—Hype ahead of evidence?
Gloria D. Coronado, David A. Lieberman
May 2026
10.3322/caac.70088
Medullary thyroid carcinoma and <i>RET</i> molecular testing: A virtual tumor board on clinical decision‐making
Lucas Kallas‐Silva, Victor Alexandre dos Santos Valsecchi et al.
May 2026
10.3322/caac.70086